183 related articles for article (PubMed ID: 27991920)
1. TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression.
Jiang C; Zhu Y; Zhou Z; Gumin J; Bengtsson L; Wu W; Songyang Z; Lang FF; Lin X
Oncogene; 2017 May; 36(20):2813-2823. PubMed ID: 27991920
[TBL] [Abstract][Full Text] [Related]
2. CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.
Jiang T; Grabiner B; Zhu Y; Jiang C; Li H; You Y; Lang J; Hung MC; Lin X
Cancer Res; 2011 Mar; 71(6):2183-92. PubMed ID: 21406399
[TBL] [Abstract][Full Text] [Related]
3. Analysis of epidermal growth factor-induced NF-κB signaling.
Jiang C; Lin X
Methods Mol Biol; 2015; 1280():75-102. PubMed ID: 25736745
[TBL] [Abstract][Full Text] [Related]
4. MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression.
Pan D; Jiang C; Ma Z; Blonska M; You MJ; Lin X
Oncogene; 2016 Feb; 35(7):919-28. PubMed ID: 25982276
[TBL] [Abstract][Full Text] [Related]
5. The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.
Pan D; Zhu Y; Zhou Z; Wang T; You H; Jiang C; Lin X
Mol Cancer Res; 2016 Jan; 14(1):93-102. PubMed ID: 26392569
[TBL] [Abstract][Full Text] [Related]
6. ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells.
Huang L; Verstrepen L; Heyninck K; Wullaert A; Revets H; De Baetselier P; Beyaert R
Oncogene; 2008 Oct; 27(47):6131-40. PubMed ID: 18622428
[TBL] [Abstract][Full Text] [Related]
7. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
Liu P; Yang P; Zhang Z; Liu M; Hu S
Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
[TBL] [Abstract][Full Text] [Related]
8. CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate.
Hou H; Li WX; Cui X; Zhou DC; Zhang B; Geng XP
World J Gastroenterol; 2019 Sep; 25(36):5483-5493. PubMed ID: 31576094
[TBL] [Abstract][Full Text] [Related]
9. CARMA3: Scaffold Protein Involved in NF-κB Signaling.
Zhang S; Lin X
Front Immunol; 2019; 10():176. PubMed ID: 30814996
[TBL] [Abstract][Full Text] [Related]
10. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
11. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway.
Wang L; Zhou W; Zhong Y; Huo Y; Fan P; Zhan S; Xiao J; Jin X; Gou S; Yin T; Wu H; Liu T
Mol Cancer; 2017 Mar; 16(1):61. PubMed ID: 28288630
[TBL] [Abstract][Full Text] [Related]
13. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells.
Bhat-Nakshatri P; Sweeney CJ; Nakshatri H
Oncogene; 2002 Mar; 21(13):2066-78. PubMed ID: 11960379
[TBL] [Abstract][Full Text] [Related]
14. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.
Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z
Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614
[TBL] [Abstract][Full Text] [Related]
15. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
[TBL] [Abstract][Full Text] [Related]
16. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
[TBL] [Abstract][Full Text] [Related]
17. Theanine from tea and its semi-synthetic derivative TBrC suppress human cervical cancer growth and migration by inhibiting EGFR/Met-Akt/NF-κB signaling.
Liu J; Sun Y; Zhang H; Ji D; Wu F; Tian H; Liu K; Zhang Y; Wu B; Zhang G
Eur J Pharmacol; 2016 Nov; 791():297-307. PubMed ID: 27612630
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Hwang YS; Lee J; Zhang X; Lindholm PF
Tumour Biol; 2016 May; 37(5):6775-85. PubMed ID: 26662305
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor (EGF) triggers the malignancy of hemangioma cells via activation of NF-κB signals.
Zhang L; Zhang J; Chen Z; Wang L; Wu X; Ou M
Biomed Pharmacother; 2016 Aug; 82():133-40. PubMed ID: 27470348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
